Lv1
100 积分 2026-06-28 加入
Systemic Inflammatory Markers of Survival in Epidermal Growth Factor-Mutated Non-Small-Cell Lung Cancer: Single-Institution Analysis, Systematic Review, and Meta-analysis
22天前
已完结
Cancer-elicited inflammation attenuates response and outcome in tyrosine kinase inhibitor naive patients with advanced NSCLC
22天前
已完结
The prognostic values of systemic immune-inflammation index and derived neutrophil-lymphocyte ratio in EGFR-mutant advanced non-small cell lung cancer
23天前
已完结
Neoadjuvant Chemoimmunotherapy for NSCLC: A Systematic Review and Meta-Analysis
1个月前
已完结
Association of pretreatment neutrophil-to-lymphocyte ratio with clinical outcomes in cancer immunotherapy: An evidence synthesis from 30 meta-analyses
1个月前
已完结
960eP Treatment patterns and clinical outcomes of stage II-III NSCLC patients receiving perioperative immunochemotherapy: A real-world study
1个月前
已完结
Improved Event-Free Survival After Complete or Major Pathologic Response in Patients With Resectable NSCLC Treated With Neoadjuvant Chemoimmunotherapy Regardless of Adjuvant Treatment: A Systematic Review and Individual Patient Data Meta-Analysis
1个月前
已完结
299P The predictive value of neutrophil-to-lymphocyte ratio (NLR) for response to neoadjuvant immunochemotherapy in resectable IIA–IIIB non-small cell lung cancer: Multicenter study
1个月前
已完结
基于外周血中性粒细胞与淋巴细胞比值构建局部晚期肺癌新辅助化疗联合免疫治疗的疗效预测模型
1个月前
已完结
皖公网安备34019202002308
